DEA Hearing Tests cannabis rescheduling Proposal
DEA hearing on cannabis rescheduling draws seven opposition groups; FDA witness defends 252-page HHS analysis, two-part CAMU test, and 2023 recommendation.
Cannabis news, weed news, marijuana news
DEA hearing on cannabis rescheduling draws seven opposition groups; FDA witness defends 252-page HHS analysis, two-part CAMU test, and 2023 recommendation.
DOJ moved FDA-approved medical cannabis to Schedule III but omitted tribal cannabis programs, leaving questions on DEA registration, supply and tax policy.
medical cannabis operators must adopt pharmacy-style GMP/GDP controls, HIPAA-grade records and clinician training after DOJ reschedules to Schedule 3.
Cannabis rescheduling prompts two companies to intervene in federal lawsuits; Congress files IBOGAINE Act; states update zoning and medical cannabis access.
marijuana rescheduling after a federal hearing leaves Connecticut cannabis operators awaiting DEA, IRS and bank actions that could change taxes, banking
Opponents present witnesses and evidence at DEA hearing on marijuana rescheduling, starting June 29 and running through July 15; DEA bars supporters and
Louisiana withdraws from DEA cannabis rescheduling hearings, leaving Idaho, Indiana, Nebraska and Tennessee opposing downgrading medical cannabis to
DEA judge faces pressure to allow cannabis rescheduling hearing livestream; Carter, Titus push marijuana scholarships; Minnesota study finds 55% pain
cannabis rescheduling hearing starts June 29; DEA named seven opposing parties and excluded rescheduling advocates. Judge Derek Julius presides through
In mid-June, a large-scale federal operation targeting illegal cannabis farms took place in Thermal, a desert community in Riverside County,…